Time Course of Postprandial Protein Metabolism
Time-dependent Regulation of Postprandial Muscle Protein Synthesis After Milk Protein Ingestion in Young Men
1 other identifier
interventional
7
1 country
1
Brief Summary
The anabolic action of 'fast' whey protein on the regulation of postprandial muscle protein synthesis has been established to be short-lived in healthy young adults. Our aim was assess the time course of anabolic signaling events and stimulation of muscle protein synthesis rates (MPS) after ingestion of a food source that represents a more typical meal-induced pattern of aminoacidemia, namely milk protein concentrate, in healthy young males.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 26, 2019
CompletedFirst Submitted
Initial submission to the registry
September 3, 2019
CompletedFirst Posted
Study publicly available on registry
October 10, 2019
CompletedOctober 10, 2019
August 1, 2019
1 month
September 3, 2019
October 7, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fractional synthesis rates of myofibrillar protein
Myofibrillar protein synthesis rates will be assessed during the postabsorptive period for 3 hours, and every 1-2 hours during the 5 hours after protein ingestion. This will allow us assess the timecourse of muscle protein synthesis after eating.
8 hours
Secondary Outcomes (2)
Phosphorylation of muscle anabolic signaling
8 hours
Exogenous rate of phenylalanine appearance
5 hours
Study Arms (1)
Milk Protein Concentrate
EXPERIMENTALSeven young men (age: 22±1 y) will undergo repeated blood and biopsy sampling during primed continuous L-\[ring-2H5\]phenylalanine and L-\[1-13C\]leucine tracer infusions, and ingested 38 g of L-\[1-13C\]phenylalanine- and L-\[1-13C\]leucine-labeled milk protein concentrate
Interventions
The macronutrient composition and energy of the milk protein beverage provided to participants is 38 g protein (3.46 g leucine), 4.17 g carbohydrate, and 1.4 g fat. The milk protein met all chemical and bacteriologic specifications for human consumption. The L-\[1-13C\]phenylalanine and L-\[1-13C\]leucine enrichments in the milk protein concentrate averaged 38.3 and 10.8 mole percent excess (MPE), respectively.
Eligibility Criteria
You may qualify if:
- Males
- Aged between 18-35 years
- Healthy, recreationally active
- BMI \< 30 kg/m2
You may not qualify if:
- Smoking
- Allergies to milk proteins
- Vegetarians
- Diagnosed GI tract diseases
- Female
- Arthritic conditions
- A history of neuromuscular problems
- Previous participation in amino acid tracer studies
- Predisposition to hypertrophic scarring or keloid formation
- Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Freer Hall
Urbana, Illinois, 61801, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2019
First Posted
October 10, 2019
Study Start
October 1, 2014
Primary Completion
November 1, 2014
Study Completion
August 26, 2019
Last Updated
October 10, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share